Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Replacement Half Year Report

30 Sep 2025 13:09

RNS Number : 4541B
Ovoca Bio PLC
30 September 2025
 

The tables in the "Half-year Report" announcement released on 30 September 2025 at 7am under RNS No 3030B were unclear and accordingly the announcement has been updated so that readers can access the tables via a pdf link now contained in the announcement.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Ovoca Bio PLC

30 September 2025

 

Ovoca Bio plc

 

("Ovoca" or the "Company")

 

Interim Results for the six months ended 30 June 2025

 

Dublin, Ireland, 30 September 2025 - Ovoca Bio announces its interim financial statements and report covering the six-months ending 30 June 2025.

 

Please click on the following link to view the full Half Year Report and extracts are set out at the end of this announcement:

 

http://www.rns-pdf.londonstockexchange.com/rns/4541B_1-2025-9-30.pdf

 

CEO Statement

Today we have published Ovoca's financial statements covering the six-month period to the end of June 2025, which I encourage all stakeholders to read. On 7 May 2025 the Company entered into a conditional Letter of Intent ("LOI") to acquire 100% of Tadeen International Limited ("Tadeen"), a UK-registered company, which indirectly owns 100% of a portfolio of mineral exploration licenses in Morocco prospective for Copper and Silver (the "Proposed Acquisition"). The team at Ovoca has been working to complete the Proposed Acquisition and in due course further announcements will be made as we finalize the acquisition of Tadeen.

 

As at 30 June 2025, the Company had cash and cash equivalents amounting to €1,526 million ($ 1,788 million) and we will continue to carefully manage our financial resources. The costs incurred during the period relate to the costs of work in relation to the Proposed Acquisition along with corporate costs.

 

I would like to thank the management team of the Company and the Board of Directors for their support.

 

End

 

For further information:

 

Ovoca Bio plc

Tim McCutcheon (Chief Executive Officer)

Tel +353 1 661 9819

info@ovocabio.com

 

Beaumont Cornish Limited (Nominated Adviser and Broker)

James Biddle/ Roland Cornish

Tel: +44 (0) 207 628 3396

 

Nominated Adviser Statement

 

Beaumont Cornish Limited ("Beaumont Cornish"), is the Company's Nominated Adviser and is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other person for providing the protections afforded to customers of Beaumont Cornish nor for advising them in relation to the transaction and arrangements described in the announcement or any matter referred to in it.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR URRURVSUKOAR
Date   Source Headline
25th Mar 20197:00 amRNSPrimary Endpoints Met in Libicore Phase III Study
31st Dec 20187:00 amRNSDirector/PDMR Shareholding
28th Sep 20187:00 amRNSInterim Results
26th Sep 20187:00 amRNSCompletion of Acquisition of IVIX
3rd Aug 20187:00 amRNSChange of Name to Ovoca Bio plc
30th Jul 20188:05 amRNSReadmission to trading on AIM and ESM
30th Jul 20188:00 amRNSEnterprise Securities Market Notice
30th Jul 20187:00 amRNSESM - Cancellation Notice
27th Jul 20182:40 pmRNSResults of Meetings
4th Jul 201810:00 amRNSESM - Schedule One
4th Jul 201810:00 amRNSSchedule 1 - Ovoca Gold Plc
4th Jul 20187:00 amRNSProposed Acquisition of IVIX
25th May 20187:00 amRNSPublication of Annual Report
23rd Nov 20177:00 amRNSResult of AGM
30th Oct 20177:00 amRNSNotice of AGM
22nd Sep 20172:45 pmRNSHolding(s) in Company
20th Sep 20176:03 pmRNSDirector/PDMR Shareholding
15th Sep 20177:00 amRNSInterim Results
12th Sep 20177:00 amRNSHolding(s) in Company
28th Jul 20172:39 pmRNSChange of Registered Office Address
30th Jun 20177:00 amRNSPublication of Annual Report
14th Feb 20177:00 amRNSChange of Registered Office
17th Aug 20167:00 amRNSResults of AGM and EGM
16th Aug 201612:00 pmRNSInterim Results
5th Aug 20162:05 pmRNSSecond Price Monitoring Extn
5th Aug 20162:00 pmRNSPrice Monitoring Extension
15th Jul 20167:00 amRNSNotice of EGM
29th Jun 20167:00 amRNSAnnual Report and Notice of AGM
13th Oct 20158:31 amRNSDirector Dealings
7th Oct 201511:20 amRNSDirector Dealings
15th Sep 20154:40 pmRNSSecond Price Monitoring Extn
15th Sep 20154:35 pmRNSPrice Monitoring Extension
27th Aug 20159:37 amRNSResult of AGM
25th Aug 20157:00 amRNSInterim Results
30th Jun 20157:00 amRNSAnnual Report and Notice of AGM
29th Apr 20157:00 amRNSTransaction in Own Shares
17th Oct 20145:00 pmRNSResults of AGM and EGM
30th Sep 20147:00 amRNSHalf Yearly Report
24th Sep 20147:00 amRNSShare Buy Back & Deferred Consideration Payment
30th Jun 20147:00 amRNSAnnual Financial Report
22nd Oct 20137:00 amRNSResource Update
2nd Oct 20137:00 amRNSHolding(s) in Company
30th Sep 20137:00 amRNSInterim Results
25th Jun 20133:22 pmRNSResult of AGM
31st May 20137:00 amRNSAnnual Report
22nd Apr 20137:00 amRNSHolding(s) in Company
17th Apr 20132:44 pmRNSHolding(s) in Company
24th Jan 20132:43 pmRNSCompletion of Disposal
16th Jan 20134:49 pmRNSResult of EGM
28th Dec 20123:45 pmRNSPublication and Posting of Circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.